Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
62.9M
-
Number of holders
-
159
-
Total 13F shares, excl. options
-
64.7M
-
Shares change
-
+3.21M
-
Total reported value, excl. options
-
$953M
-
Value change
-
+$51.5M
-
Put/Call ratio
-
0.1
-
Number of buys
-
90
-
Number of sells
-
-65
-
Price
-
$14.72
Significant Holders of MACROGENICS INC - COM (MGNX) as of Q1 2024
186 filings reported holding MGNX - MACROGENICS INC - COM as of Q1 2024.
MACROGENICS INC - COM (MGNX) has 159 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.7M shares
.
Largest 10 shareholders include Bellevue Group AG (9.97M shares), Avoro Capital Advisors LLC (6.15M shares), BlackRock Inc. (5.7M shares), STATE STREET CORP (4.39M shares), VANGUARD GROUP INC (3.68M shares), T. Rowe Price Investment Management, Inc. (2.77M shares), Frazier Life Sciences Management, L.P. (2.47M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.44M shares), ARMISTICE CAPITAL, LLC (2.4M shares), and RA CAPITAL MANAGEMENT, L.P. (2.08M shares).
This table shows the top 159 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.